SafeAlleleSCA, a pioneering precision gene therapy project for Machado–Joseph disease, has been awarded the €100,000 Jorge Ruas Award at the Final Event of the Tecnimede Open Innovation Competition 2026, held on 27 May at the Pavilhão do Conhecimento in Lisbon.